Clinical Trials Browser

Phase 2 × Adenocarcinoma of Lung × farletuzumab × Clear all

NCT01218516 2020-08-20

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Phase 2 Completed

130 enrolled 11 charts

Adenocarcinoma of Lung